Reltecimod
Reltecimod is a CD28 antagonist investigated for the treatment of severe infections like necrotizing soft tissue infection. Its mechanism involves modulating T-cell co-stimulation, with research applications in immunology and sepsis studied in both in vitro and in vivo experimental models.
Product Specifications
Field of Research
Immunology & Inflammation, Infectious Disease & Virology
Molecular Weight
1037.19
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
